Overview

VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia

Status:
Active, not recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate the safety and effectiveness of treating myopia (short-sightedness) higher than -10D using small incision lenticule extraction (SMILE) with the VisuMax femtosecond laser.
Phase:
N/A
Details
Lead Sponsor:
London Vision Clinic
Treatments:
Anesthetics
BB 1101
Benoxinate
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Levofloxacin
Ofloxacin
Procaine
Propoxycaine
Proxymetacaine
Tobramycin